This partnership will enable the CRO Worldwide Clinical Trials to use Datavant’s software, which provides a holistic view of anonymous datasets by combining multiple data layers into a single de-identified dataset in focusing on understanding why neurodegenerative disease clinical trials fail.

https://www.outsourcing-pharma.com/Article/2018/05/10/Worldwide-and-Datavant-tackling-neurodegenerative-study-design-in-new-partnership?utm_source=newsletter_daily&utm_medium=email&utm_campaign=10-May-2018&c=B5LaTvdHM6BGC4unlN6013fIdWCrEKoG&p2=